Effect of 10 years' hormone replacement therapy on bone mineral content in postmenopausal women

Bone

Volumn 19, Issue 5 SUPPL., 1996, Pages 191S-193S

  Eiken, Pia ^a   Kolthoff, N ^a   Pors Nielsen, S ^a  

^a HILLERØD HOSPITAL   (Denmark)

Author keywords

Bone mineral density; Estrogen; Hormone replacement therapy; Menopause; Osteoporosis; Progestogen

Indexed keywords

ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; GESTAGEN; NORETHISTERONE ACETATE; TRISEQUENS;

BONE ATROPHY; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; FOREARM; HORMONE SUBSTITUTION; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

EID: 0029958736     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(96)00266-9     Document Type: Conference Paper

References (28)

1. Abdalla, H. I., Hart, B. M., Lindsay, R., et al. Prevention of bone mineral loss in postmenopausal women with norethisterone. Obstet Gynecol 66:789-792; 1985.
2. Barentsen, R., Groeneveld, F. P. M. J., Bareman, F. P., et al. Women's opinion on withdrawal bleeding with hormone replacement therapy. Eur J Obstet Gynecol Reprod Biol 51:203-207; 1993.
3. Christiansen, C., Christiansen, M. S., McNair, P. L., et al. Prevention of early postmenopausal bone loss: Conducted 2-year study of 315 normal females. Eur J Clin Invest 10:273-279; 1980.
4. Christiansen, C., Christiansen, M. S., and Transbøl, I. B. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet 1:459-461; 1981.
5. Consensus Development Conference. Prophylaxis and treatment of osteoporosis. Am J Med 90:107-110; 1991.
6. Dennison, E. and Cooper, C. The epidemiology of osteoporosis. Br J Clin Pract 50:33-36; 1996.
7. Eiken, P., Bärenholdt, O., Bjørn Jensen, L., et al. Switching from DXA pencil-beam to fan-beam. I: Studies in vitro at four centers. Bone 15:667-670; 1994.
8. Eiken, P. and Kolthoff, N. Compliance with long-term oral hormonal replacement therapy. Maturitas 22:97-103; 1995.
9. Ettinger, B., Genant, H. K., and Cann, C. E. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 102:319-324; 1985.
10. Gotfredsen, A., Nilas, L., Riis, B. J., et al. Bone changes occurring spontaneously and caused by estrogen in early postmenopausal women: A local or generalised phenomenon? Br Med J 292:1098-2000; 1986.
11. Hahn, R. G. Compliance considerations with estrogen replacement: Withdrawal bleeding and other factors. Am J Obstet Gynecol 161:1854-1858; 1989.
12. Hutchinson, T. A., Polansky, S. M., and Feinstein, A. R. Post-menopausal oestrogen protects against fractures of the hip and distal radius. A case-control study. Lancet 2:705-709; 1979.
13. Johnson, R. E. and Sprecht, E. E. The risk of hip fracture in postmenopausal women with or without estrogen drug exposure. Am J Public Health 71:138-144; 1981.
14. Keil, D. P., Felson, D. T., Anderson, J. J., et al. Hip fracture and the use of estrogens in postmenopausal women. N Engl J Med 317:1169-1174; 1987.
15. Kreiger, N., Kelsey, J. L., Holford, T. R., and O'Connor, T. An epidemiologic study of hip fracture in postmenopausal women. Am J Epidemiol 116:141-148; 1982.
16. Lindsay, R., Aitken, J. M., Anderson, J. B., et al. Long-term prevention of postmenopausal osteoporosis by oestrogen treatment. Lancet 1:1038-1041; 1976.
17. Lindsay, R., Hart, D. M., Forrest, C., and Baird, C. Prevention of spinal osteoporosis in oophorectomised women. Lancet 2:1151-1153; 1980.
18. Mazess, R. B. Bone density in diagnosis of osteoporosis: Thresholds and breakpoints. Calcif Tissue Int 41:117-118; 1987.
19. Munk-Jensen, N., Pors Nielsen, S., Obel, E. B., and Bonne Eriksen, P. Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: A double blind placebo controlled study. Br Med J 296:1150-1152; 1988.
20. Naessén, T., Persson, I., Adami, H.-O., et al. Hormone replacement therapy and risk of first hip fracture. A prospective, population-based cohort study. Ann Intern Med 113:95-103; 1990.
21. Obel, E. B., Munk-Jensen, N., Svenstrup, B., et al. A two-year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment. Maturitas 16:13-21; 1993.
22. Paganini-Hill, A., Ross, R. K., Gerkins, V. R., et al. Menopausal estrogen therapy and hip fractures. Ann Intern Med 95:28-31; 1981.
23. Pors Nielsen, S., Bärenholdt, O., Hermansen, F., and Munk-Jensen, N. Magnitude and pattern of skeletal response to long term continuous and cyclic sequential oestrogen/progestin treatment. Br J Obstet Gynaecol 101:319-324; 1994.
24. Rees, M. On menstrual bleeding with hormone replacement therapy. Lancet 343:250; 1994.
25. Rowe, R. Preventative strategies: Is current clinical practice effective for bones? Br J Clin Pract 50:47-49; 1996.
26. Riis, B. J., Thomsen, K., Strøm, V., and Christiansen, C. The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss. Am J Obstet Gynecol 156:61-65; 1987.
27. Rozenbaum, H. and Birkhäuser, M. H. Consensus Propositions. Birkhäuser M. H. and Rozenbaum H., Eds. Menopause, European Consensus Development Conference, Montreux, Switzerland. Editions ESKA, Paris; pp. 293-303, 1996.
28. Weiss, N. S., Ure, C. L., Ballard, J. H., et al. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 303:1195-1198; 1980.